Decoy Therapeutics Inc.
DCOY
$2.99
$0.010.34%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -183.14% | -134.00% | -124.52% | -0.22% | 21.05% |
| Total Depreciation and Amortization | 454.55% | 170.45% | 61.36% | 0.00% | -50.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5,322.12% | 3,778.93% | 3,089.77% | -57.64% | -65.83% |
| Change in Net Operating Assets | -479.71% | -346.56% | -235.48% | 171.24% | 145.77% |
| Cash from Operations | -100.92% | -50.12% | -6.67% | 16.26% | 46.10% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 72.19% | 52.46% | 37.84% | 30.13% |
| Issuance of Common Stock | 621.28% | 446.98% | 724.68% | 326.90% | 2,259.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | 71.12% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 806.53% | 563.12% | 1,064.06% | 517.43% | 386.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 402.45% | 333.89% | 338.80% | 135.51% | 70.03% |